The antibiotic ciprofloxacin (Cipro®) has been found to be effective in treating bacterial infections and preventing the spread of bacterial infections. Ciprofloxacin belongs to a group of drugs called tetracycline antibiotics.
This antibiotic has also been proven to be effective in treating various types of bacterial infections. It is available in both oral and intravenous forms and is a prescription medication.
Ciprofloxacin is a broad-spectrum antibiotic that can be used to treat bacterial infections, such as urinary tract infections, respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases. It is also used to treat infections of the eye, such as conjunctivitis, keratitis, and bacterial conjunctivitis.
Ciprofloxacin is most effective when taken orally as a single dose. This drug is usually prescribed for adults over the age of 18 who have a bacterial infection. It can be taken with or without food, and it is important to take the medication at the same time each day.
The oral tablet forms of Ciprofloxacin are manufactured in the same laboratory as the tablets. The tablets are available in 250 mg, 500 mg, or 1000 mg strengths. The dosage of Ciprofloxacin tablets should be taken according to the instructions given to your healthcare provider. Do not take more than the prescribed dose or take it for longer than recommended by your healthcare provider.
Oral antibiotics can cause severe and potentially life-threatening infections in humans, especially when taken orally. In the United States, a recent study evaluated the risk of oral antibiotic-associated urinary tract infection (AUEI) in children in the community, and found that oral antibiotics, including amoxicillin, can cause AUEI in 2.3% of children.
This is a prospective, open-label study of children aged 2–6 years in the community, with or without AUEI, at medical and dental school level. A total of 4200 children from 2,927 community sites were included. The study was approved by the Research Ethics Board at the University of California, San Francisco. The study was conducted in accordance with the Declaration of Helsinki.
The risk of AUEI was significantly higher in children with AUEI compared to those with no AUEI or in the general population of the study population. However, there were no differences between the risk of AUEI and the risk of other AUEIs in the general population of the study population (i.e., younger, urban and rural children).
Oral antibiotics are a safe and effective alternative to oral antibiotics in reducing AUEI in children. However, in the context of a broader public health issue, the risk of AUEI in children is high.
A range of antimicrobial agents has been shown to cause AUEI and related health issues, including urinary tract infections and the development of a number of potentially life-threatening infections.1,2,3 In the United States, a recent study evaluated the risk of AUEI in children, and found that oral antibiotics, including amoxicillin, can cause AUEI in 2.3% of children.
In the United States, a recent study evaluated the risk of AUEI in children, and found that oral antibiotics, including amoxicillin, can cause AUEI in 2.3% of children.
The most common antibiotic used to treat AUEI in children in the United States is a penicillin-type antibiotic called amoxicillin. This includes the drug ciprofloxacin, and is also known as a fluoroquinolone antibiotic, including the drug quinolone.4,5 A PubMed abstract also reported that AUEI in children could cause AUEI in 2.3% of children.5,6 A PubMed abstract also reported that the risk of AUEI in children could be higher when antibiotics are taken orally.
In the context of a broader public health issue, the risk of AUEI in children is high. A recent study examined the risk of AUEI in children in the community, and found that oral antibiotics, including amoxicillin, can cause AUEI in 2.3% of children.7 This risk can be higher if antibiotics are taken orally, which may reduce the risk of AUEI in children.8
A retrospective, prospective cohort study was conducted at medical and dental school level in the United States from June 2005 to March 2007. All children enrolled from medical and dental school levels were identified via the United States Food and Drug Administration (U. S. FDA) website. For each child, a detailed medical history was taken, including the diagnosis of AUEI, the date of onset, and the time of exposure.
All patients in the study were reviewed by their pediatric medical physician, who then reviewed the medical records of patients with AUEI, who had AUEI in the general population. The details of the study design and the patients’ age, gender, sex, and race were recorded.
A total of 5,849 patients with AUEI from the study were identified, with a total of 8,942 (74.5%) patients with AUEI. Of these patients, 4,853 (37.5%) were women and 5,979 (37.5%) were men. The mean age was 3.9 years. The patients’ medical records of all patients were reviewed by the same researchers.
The combination of Ciprofloxacin and Tinidazole is indicated for the management of a wide variety of infections caused by susceptible gram-positive and gram-negative organisms along with anaerobes and protozoa.
Ciprofloxacin: Antibiotics (Quinolone antibiotics)
Tinidazole : Antiprotozoals
Ciprofloxacin + Tinidazole effectively manages infection, where ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria. Tinidazole works by killing the parasites and anaerobic bacteria that are responsible for causing infections by damaging their DNA.
Consult your doctor:
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use only afterMEDS GO Class 3Properties:A powerful anti-seizure medicine with rapid and reliable onset in early pregnancy, and no significant impact on breast milk. Contains ciprofloxacin as an active ingredient. Ciprofloxacin is a broad spectrum antibiotic with a high affinity for the tetracycline-penicillins resistant class of antibiotics. Use as a prophylactic or even as a maintenance therapy. It works differently than other classes of antibiotics like penicillin, cephalosporin and sulfonamides. For external use only.Unless stated otherwise if for any reason ciprofloxacin-susceptible organisms were not found.
Pregnancy: Use only if clearly needed. Maintaining good fluid balance and avoiding excessive fluid intake is strongly recommended during pregnancy. Do not use if allergic to ciprofloxacin or other quinolones. Ciprofloxacin may cause fetal harm if exposed to alcohol or strong sunlight. Inform your doctor if you are pregnant or planning to become pregnant. Do not use if alcohol is a risk factors for birth defects of the fetus, especially in the third trimester. Do not use if your immune system is compromised or you are breast-feeding.Lactation: Ciprofloxacin is used with or without food to decrease the likelihood of yeast infections. Do not use if lactation is not adequate for you. Ciprofloxacin-susceptible organisms are more likely to be resistant to other antibiotics or to be resistant to other antibiotics. Therefore, use with caution and do not exceed the recommended dose. Lactation for longer period of time may affect the quality of life. Inform your doctor if you are planning to use ciprofloxacin-susceptible organisms during your pregnancy or if you are breastfeeding.All medicines may cause side effects. Some of them are reversible upon change of the affected drug or treatment with another drug. In such cases, seek immediate medical attention.
[Generic Equivalent Of Cipro]
Prescription Required
Quantity:30
Price:$89.99$1.23 per unit
Country:Canada
Please Select... 30 from Canada $89.99 60 from India $99.99 60 from India $79.99
* The product images are for reference only. Generic equivalents may also be supplied by alternate manufacturers.
Ciprofloxacin 500 mg tab is a generic drug used to treat bacterial infections of the skin and respiratory tract in Canada. It is manufactured by Bayer, Inc., the result of research and development. It is available in the quantity of 30, 60, 90 and 100 tablets.
Generic medicines are generally cheaper than brand-name medicines.
Generic Ciprofloxacin 500 mg tab offers a wide variety of benefits for Canadians, including the following:
Tablets
90 from Canada $89.99 60 from India $79.99 60 from India $59.99 60 from India $59.99
Product Name:Ciprofloxacin 500 mg tab
Product Type:Tablet
Form:Capsules (30, 60, 90, 100 tablets)
Product Strength:500 mg
Manufacturer: Bayer, Inc.